• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Weekly Roundup: October 18-22


ICYMI, some of this week’s featured content includes an exclusive interview about eczema, and articles on a new tralokinumab data, apremilast as a combination treatment, and more.

POLL: Are you attending Fall Clinical Dermatology Conference 2021 this weekend?

Study: Apremilast for Combination Therapy

A review of apremilast combination therapies was recently published in the Journal of Drugs in Dermatology, examining treatment efficacy and safety.

AI Breakthrough in Melanoma Detection

Proscia announces new study data on artificial intelligence’s ability to detect melanoma.

A Revolutionary Way to Revive Sensitive Skin

With the release of three brand-new products, ALASTIN Skincare® is introducing a new line of sensitive skin products that include our proprietary TriHex Technology® along with other active ingredients.

Cynosure RF Microneedling System Cleared in Canada

Potenza, Cynosure’s RF microneedling system, has been cleared by Health Canada.

DermView Episode 1: Environmental Factors and Ezcema

In this episode of DermView, Adelaide Hebert, MD, explains how eczema can lead to growth issues in pediatric patients, how environmental factors may play a role in flare ups, and more.

Galderma Celebrates Restylane’s 25th Anniversary

On September 30, 2021, Galderma celebrated its 25th anniversary of its Restylane line of hyaluronic acid fillers.

FDA Approves Adalimumab-adbm as First Interchangeable Biosimilar with Adalimumab

The approval was supported by promising phase 3 data of the VOLTAIRE-X clinical trial.

Tap the Tax, Savings Potential of Cash Balance Plans

O’Dell is the managing partner with OJM Group in Cincinnati, Ohio, a financial consultant, and the author of more than a dozen books on wealth management for doctors. Foos is a partner and lead tax consultant with OJM Group in Cincinnati, Ohio.

Investigators Develop New Vitiligo Impact Treatment Score

Investigators believe the new instrument could be generalized to other chronic inflammatory skin diseases in future studies.

Pointers With Dr Portela: Can Keratosis Pilaris Be Cured?

In this week’s Pointers with Dr Portela, the 208SkinDoc explains what keratosis pilaris is and whether or not it can be cured.

The Cutaneous Connection: Hair Loss Trends, Challenges, and Prevention

This episode of The Cutaneous Connection podcast, Gary Linkov, MD, dives into the topic of hair loss.

Nonsteroidal Topical Therapies

Neal Bhatia, MD, gives a thumbs down on the phrase “steroid alternatives”.

Applying GEP to Melanoma Detection

How can GEP be applied to melanoma diagnosis and treatment? Darrel Rigel, MD, MS, answers these questions and dives into the data at Fall Clinical Dermatology Conference 2021.

If Approved, Cantharidin 0.7% Could be Standard of Molluscum Care

Cantharidin 0.7% could be an emerging standard for molluscum treatment.

Tralokinumab Meets Endpoints in Adolescent AD Trial

LEO Pharma releases the 16-week data regarding tralokinumab (Adtralza; LEO Pharma) as a treatment for adolescent patients aged 12 to 17 years.

COVID-19 Skin Symptoms in Children

Lawrence Eichenfield, MD, provides the newest updates in pediatric patient care, with a special update on COVID-19 skin symptoms in children.

GEP in Melanoma Detection with Darrell S. Rigel, MD, MS

In a video onsite at Fall Clinical Dermatology Conference, Darrell S. Rigel, MD, MS, highlights, in his own words, the potential of GEP as an adjunct to biopsy in melanoma detection.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.